Market Overview

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018-2020 - ResearchAndMarkets.com

Share:

The "Familial
Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's
Disease) - Global API Manufacturers, Marketed and Phase III Drugs
Landscape, 2018"
drug pipelines has been added to ResearchAndMarkets.com's
offering.

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de
Andrade's Disease) - Global API Manufacturers, Marketed and Phase III
Drugs Landscape, 2018 report provides comprehensive insights about
marketed and Phase III products for Familial Amyloid Polyneuropathy
(Transthyretin Amyloidosis, Corino de Andrade's Disease).

Coverage of API manufacturers for Familial Amyloid Polyneuropathy
(Transthyretin Amyloidosis, Corino de Andrade's Disease) marketed
products spanning across United States, Europe, China and India. The
manufacturers' details include manufacturers' names along with their
locations.

This report provides a comprehensive understanding of the emerging Phase
III therapies for Familial Amyloid Polyneuropathy (Transthyretin
Amyloidosis, Corino de Andrade's Disease) which can turn out to be
future prospective competitors for the marketed products. It will also
put light on the current market trends. Their forecasted global sales
are also provided till 2020.

Key Topics Covered:

1. Report Introduction

2. Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis,
Corino de Andrade's Disease): Overview

3. Comparative Analysis of Marketed and Emerging Products

4. Marketed Therapies

  • Product Description
  • Route of Synthesis
  • Mechanism of Action
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Adverse Reactions
  • Clinical Trials
  • Regulatory Milestones
  • Product Development Activities

5. Emerging Therapies (Phase III)

  • Product Description
  • Research and Development
  • Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/lfqp28/familial_amyloid?w=4

View Comments and Join the Discussion!